MedPath
NMPA Approval

Insulin icodec Injection

国药准字SJ20240019

June 18, 2024

Drug Information

依柯胰岛素注射液

诺和期

注射剂

3ml:2100单位(畅充)

生物制品

June 18, 2024

June 17, 2029

Company Information

Applicant Company

Novo Nordisk A/S

Novo Alle 1, DK-2880 Bagsvaerd, Denmark

Manufacturing Company

Novo Nordisk A/S

Brennum Park 1, DK-3400 Hilleroed, Denmark

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

依柯胰岛素注射液 - NMPA 批准文号 | MedPath